An Israeli-American drug company is developing a new drug that its makers say may be able to treat both skin cancer and psoriasis. The drug, currently called HBP-347, is based on an extract found in St. John's Wort and is formulated after the naturally occurring chemical compound hypericin. The company says the skin cancer drug could be available in as little as three years.
Read moreSwedish studies indicate that a drug that is activated by light exposure may be the answer for tens of thousands of skin cancer patients. ... Read more »
Hi everyone. Today, I would like to discuss how skin cancers are treated. It has been my experience that many people know little about... Read more »
One of the concerns you may have as a skin cancer patient is how you will afford the cost of physician visits, medical procedures, and... Read more »
Many of you have had questions about treatment to remove non-melanoma skin lesions. We have talked extensively about Mohs Surgery as a... Read more »
Each week, Health and Beauty Expert Sue Chung will discuss skin health topics suggested by members of the HealthCentral community. To ask... Read more »
A British company has designed a Band-Aid adhesive bandage that emits light that may treat skin cancer. Previous research has found that skin cancer... Read more »
Researchers have found that tea tree oil may be a fast, inexpensive, and effective treatment for some forms of skin cancer. In a recent study,... Read more »
A type of skin cancer called nodular melanoma accounts for 14 percent of diagnosed skin cancers, but 37 percent of fatal cases, a new study has... Read more »
A review of previous studies has found a link between the use of tumor necrosis factor (TNF) inhibitors such as Remicade (infliximab), Enbrel... Read more »
Source: ADAM Encyclopedia
MelanomaMelanoma accounts for only 5% of all skin cancers, yet it results in most of the skin cancer deaths, according to the American Cancer... Read more »